outlined by Sen. Ron Wyden
“It makes sense to get buy-in before releasing it rather than releasing it with fingers crossed and then tweaking it once members complain,” the aide said. An analysis from Patients for Affordable Drugs found that PhRMA and other advocacy groups aligned on the issue, including the conservative group American Action Network partially funded by PhRMA, have spent upwards of $18 million on ads opposing the Medicare negotiation proposal since July.
PhRMA spent $6.43 million on lobbying during the second quarter of this year, which runs from April through June, a 19 percent increase over the same period in 2020.
Responsible journalism: Getting worried about the serious push from Democrats in reigning in drug prices, drug industry is left with no clout other than to make the tenuous connection that such a push would hurt the ability of the industry to respond to future Covid variants.
Dems push for prices to go ⤴️⬆️⬆️⬆️up. Pharma got them in their wallets.
'We did the right thing once... now let us continue having people choosing between food and medicine, please... we only have two yachts, how can you expect us to live like... peasants?'
Is it COVID clout or is it lobbyists with truckloads of money?